CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 871,409 Value ($000) $5,237 Avg Close Range
Q2 2022
Shares 102,333 Value ($000) $611 Avg Close Range
Q1 2022
Shares 44,136 Value ($000) $206 Avg Close Range
Q1 2019
Shares 218,273 Value ($000) $212 Avg Close Range
Q4 2018
Shares 922,655 Value ($000) $677 Avg Close Range
Q3 2018
Shares 300,000 Value ($000) $648 Avg Close Range
Q2 2018
Shares 312,916 Value ($000) $1,558 Avg Close Range